59 related articles for article (PubMed ID: 23224727)
1. Prostaglandin E2 alteration in contraceptive consumers: as a risk factor for inflammatory diseases.
Sanjary Pour M; Fallah S; Rabbani Chadegani A
Arch Gynecol Obstet; 2013 May; 287(5):1031-7. PubMed ID: 23224727
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers.
Fallah S; Sanjary Pour M; Rabbani Chadegani A; Korani M
Arch Gynecol Obstet; 2012 Jun; 285(6):1747-52. PubMed ID: 22210292
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
Kasule J; Mbizvo M; Makuyana D; Masona D
Cent Afr J Med; 1991 Dec; 37(12):403-9. PubMed ID: 1806254
[TBL] [Abstract][Full Text] [Related]
4. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
5. Contraceptive methods and risk factors of cardiovascular diseases in Tehranian women: Tehran Lipid and Glucose Study.
Azizi F; Ainy E; Mirmiran P; Habibian S
Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):1-6. PubMed ID: 12041858
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral contraceptive use on lipid profile in Korean women aged 35-55 years.
Kim K; Park H
Contraception; 2012 Nov; 86(5):500-5. PubMed ID: 22625865
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure, serum total cholesterol and contraceptive pill use in 17-year-old girls.
Nawrot TS; Den Hond E; Fagard RH; Hoppenbrouwers K; Staessen JA
Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):438-42. PubMed ID: 14671466
[TBL] [Abstract][Full Text] [Related]
8. Serum lipids in women on oral contraceptives in Zaria-Nigeria.
Yahaya IA; Afonja OA
Niger Postgrad Med J; 2005 Jun; 12(2):85-8. PubMed ID: 15997254
[TBL] [Abstract][Full Text] [Related]
9. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
Creasy GW; Fisher AC; Hall N; Shangold GA
J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
13. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
15. A comparison of plasma cholesterol, triglycerides and high density lipoprotein cholesterol levels in women using contraceptive pills and a control group.
Yeshurun D; Barak C; Blumensohn R; Rosenzweig B
Gynecol Obstet Invest; 1984; 18(4):169-73. PubMed ID: 6510775
[TBL] [Abstract][Full Text] [Related]
16. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
18. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
19. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
Boyet F
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
[TBL] [Abstract][Full Text] [Related]
20. Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort.
Boyer JF; Bongard V; Cantagrel A; Jamard B; Gottenberg JE; Mariette X; Davignon JL; Ferrières J; Ruidavets JB; Dallongeville J; Arveiler D; Cambon-Thomsen A; Constantin A
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):872-80. PubMed ID: 22275176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
